This trial was a randomized , two-armed , non-inferiority phase @ comparison of CapeOX ( capecitabine @ mg/m@ twice daily on days @-@ and oxaliplatin @ mg/m@ on day @ ) versus SOX ( S-@ @ mg/m@ twice daily on days @-@ and oxaliplatin @ mg/m@ on day @ ) .